Plato, Munro invest in SpaceX as rival funds wait for the sellers

“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.

Alex Gluyas

Plato, Munro invest in SpaceX as rival funds wait for the sellers

June 11, 2026
“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.
Read Transcript

Munro Partners and Plato Investment Management are among the few Australian growth funds to invest in Elon Musk’s SpaceX IPO while most of their rivals are sitting back until the world’s hottest stock becomes cheaper.

Nick Griffin, chief investment officer of the $9.1 billion money manager Munro Partners, said he was making a small investment in the rocket company, which is set to hit the boards in New York on Friday (Saturday AEST).

While Griffin acknowledged that SpaceX’s $US1.8 trillion ($2.57 trillion) valuation was expensive, he wanted to ensure that Munro had some exposure should the stock continue to surge well beyond its market debut.

“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.

The investment chief thinks that opportunity could present itself in a matter of months when insider lock-ups expire and private investors start to cash in.

Musk himself has agreed not to sell any of his roughly 40 per cent stake for at least a year after the IPO.

“If you look at the big IPOs such as Google, Facebook, Uber and even Spotify, there’s so much money that had to come out, so many private investors in SpaceX will have to sell in the next 12 months or two years,” Griffin said. “That private-to-public hand-off usually provides opportunities.”

Plato Investment Management is adopting a similar strategy and is buying shares via the IPO to build a position that will be roughly in line with SpaceX’s weighting on the index.

“[It is] enough to avoid being badly wrong if these businesses do become the next Amazon or Nvidia, but not so much that we’re hostage to a valuation that leaves no room for error,” said David Allen, who runs Plato’s $4.2 billion Global Alpha Fund.

Allen warned that SpaceX was trading on a price to revenue of 100 times, which implied that everything needed to go right for the company, including the technology, competition, regulation and execution.

“When you pay 100 times revenue for a business, you’re not buying a company, you’re buying a specific version of the future,” said the hedge fund manager.

“In our experience, the future has a habit of surprising even the most careful forecasters.”

While Allen has said that SpaceX was likely to make an attractive short in the future – that is when an investor makes money from a stock’s decline – he warned that building a short position now was fraught with risk.

“With a wave of retail money chasing what will likely be a limited free float at IPO, there’s little upside in betting heavily against these on day one,” he said.

While Plato and Munro are dabbling in SpaceX, some fund managers are holding back for now, while others, including Antipodes, are avoiding the company altogether.

A ‘trust me’ story


Alex Pollak, who runs Loftus Peak’s $1.5 billion Global Disruption strategy, said while SpaceX would likely rally in the first few sessions of trading at least, he was still happy to watch from the sidelines.

Pollak pointed to S&P’s decision not to change the rules for a company to join its major indices. That policy contrasted with rivals Nasdaq and FTSE Russell, which recently tweaked their ​requirements.

To join the S&P 500 Index, a company must trade publicly for at least a year, be ‌profitable under US accounting standards and hold a free float of at least 10 per cent. SpaceX meets none of those requirements.

The rocket company posted a net loss of $US4.9 billion last year, while revenue rose 33 per cent ​to $18.6 billion. It has never been profitable.

“The float is clearly oversubscribed and the stock will probably go up, but we’re not investors,” said Pollak.

“To win a place in our portfolio, you need to have the possibility of stock price performance, and risks have to be controlled, but that is not the case with SpaceX because it’s just a ‘trust me’ story.”

Ziller Funds Management has also opted out despite SpaceX ticking many of the boxes required to be eligible for a position in its Ziller Global Fund, including the company being led by its billionaire founder.

Investment chief Joseph Ziller said he was bullish on the space theme, but not on the hefty valuation.

“Reliable launch is in extremely short supply because it’s incredibly difficult to do,” said Ziller.

“The only two players doing it are SpaceX and Rocket Lab, so the supply-constrained nature of the industry means the unit economics are very attractive.”

Ziller held a stake in Rocket Lab but has recently trimmed its position, given the stock has almost quadrupled in value over the past year.

“SpaceX is a similar situation – we’re not so interested at these valuations,” Ziller said. “There will be an opportunity over the next six months to 12 months to get in at a more attractive price.”

Hedge fund manager Jack Hu, who runs the Phoenix Growth Fund, built up a position in SpaceX earlier in the year after taking part in a funding round.

While that stake will be subject to a mandatory lock-up period, Hu has applied for another allocation through the IPO.

If successful, Hu said he planned to sell those shares in the first few days of trading as passive and benchmark-aware investors send the stock soaring.

Munro Partners and Plato Investment Management are among the few Australian growth funds to invest in Elon Musk’s SpaceX IPO while most of their rivals are sitting back until the world’s hottest stock becomes cheaper.

Nick Griffin, chief investment officer of the $9.1 billion money manager Munro Partners, said he was making a small investment in the rocket company, which is set to hit the boards in New York on Friday (Saturday AEST).

While Griffin acknowledged that SpaceX’s $US1.8 trillion ($2.57 trillion) valuation was expensive, he wanted to ensure that Munro had some exposure should the stock continue to surge well beyond its market debut.

“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.

The investment chief thinks that opportunity could present itself in a matter of months when insider lock-ups expire and private investors start to cash in.

Musk himself has agreed not to sell any of his roughly 40 per cent stake for at least a year after the IPO.

“If you look at the big IPOs such as Google, Facebook, Uber and even Spotify, there’s so much money that had to come out, so many private investors in SpaceX will have to sell in the next 12 months or two years,” Griffin said. “That private-to-public hand-off usually provides opportunities.”

Plato Investment Management is adopting a similar strategy and is buying shares via the IPO to build a position that will be roughly in line with SpaceX’s weighting on the index.

“[It is] enough to avoid being badly wrong if these businesses do become the next Amazon or Nvidia, but not so much that we’re hostage to a valuation that leaves no room for error,” said David Allen, who runs Plato’s $4.2 billion Global Alpha Fund.

Allen warned that SpaceX was trading on a price to revenue of 100 times, which implied that everything needed to go right for the company, including the technology, competition, regulation and execution.

“When you pay 100 times revenue for a business, you’re not buying a company, you’re buying a specific version of the future,” said the hedge fund manager.

“In our experience, the future has a habit of surprising even the most careful forecasters.”

While Allen has said that SpaceX was likely to make an attractive short in the future – that is when an investor makes money from a stock’s decline – he warned that building a short position now was fraught with risk.

“With a wave of retail money chasing what will likely be a limited free float at IPO, there’s little upside in betting heavily against these on day one,” he said.

While Plato and Munro are dabbling in SpaceX, some fund managers are holding back for now, while others, including Antipodes, are avoiding the company altogether.

A ‘trust me’ story


Alex Pollak, who runs Loftus Peak’s $1.5 billion Global Disruption strategy, said while SpaceX would likely rally in the first few sessions of trading at least, he was still happy to watch from the sidelines.

Pollak pointed to S&P’s decision not to change the rules for a company to join its major indices. That policy contrasted with rivals Nasdaq and FTSE Russell, which recently tweaked their ​requirements.

To join the S&P 500 Index, a company must trade publicly for at least a year, be ‌profitable under US accounting standards and hold a free float of at least 10 per cent. SpaceX meets none of those requirements.

The rocket company posted a net loss of $US4.9 billion last year, while revenue rose 33 per cent ​to $18.6 billion. It has never been profitable.

“The float is clearly oversubscribed and the stock will probably go up, but we’re not investors,” said Pollak.

“To win a place in our portfolio, you need to have the possibility of stock price performance, and risks have to be controlled, but that is not the case with SpaceX because it’s just a ‘trust me’ story.”

Ziller Funds Management has also opted out despite SpaceX ticking many of the boxes required to be eligible for a position in its Ziller Global Fund, including the company being led by its billionaire founder.

Investment chief Joseph Ziller said he was bullish on the space theme, but not on the hefty valuation.

“Reliable launch is in extremely short supply because it’s incredibly difficult to do,” said Ziller.

“The only two players doing it are SpaceX and Rocket Lab, so the supply-constrained nature of the industry means the unit economics are very attractive.”

Ziller held a stake in Rocket Lab but has recently trimmed its position, given the stock has almost quadrupled in value over the past year.

“SpaceX is a similar situation – we’re not so interested at these valuations,” Ziller said. “There will be an opportunity over the next six months to 12 months to get in at a more attractive price.”

Hedge fund manager Jack Hu, who runs the Phoenix Growth Fund, built up a position in SpaceX earlier in the year after taking part in a funding round.

While that stake will be subject to a mandatory lock-up period, Hu has applied for another allocation through the IPO.

If successful, Hu said he planned to sell those shares in the first few days of trading as passive and benchmark-aware investors send the stock soaring.

Disclaimer: This material has been prepared by Australian Financial Review, published on June 11, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
January 7, 2026

What top fundies learned in 2025, and how they'll act on it 2026

With 2025 almost in the rearview mirror, Livewire Markets spoke to some of Australia's top fund managers to reflect on the lessons they learned (or relearned) and how it's informing their strategy going forward.

Read More
January 12, 2026

WINNING THE ROOM with Chief Investment Officer Nick Griffin

Sohn Hearts & Minds Creative Director Jonathan Pease spoke with Nick Griffin, Founding Partner & Chief Investment Officer of Munro Partners (Core Fund Manager). Tune in for his fascinating insights, with a particular focus on Artificial Intelligence.

Read More
Steven Marks presenting at the 2023 Sohn Hearts & Minds Conference (credit: Renee Nowytarger)Steven Marks presenting at the 2023 Sohn Hearts & Minds Conference (credit: Renee Nowytarger)Steven Marks presenting at the 2023 Sohn Hearts & Minds Conference (credit: Renee Nowytarger)Steven Marks presenting at the 2023 Sohn Hearts & Minds Conference (credit: Renee Nowytarger)
February 3, 2026

Why GYG’s Steven Marks refuses to compromise on quality

Founder of Guzman y Gomez, Steven Marks, joins Matthew Kidman to discuss his decision to leave Wall Street, the tough early years building GYG, why quality is non-negotiable, and what comes next as the business expands into the US.

Read More
QIao Ma presenting at the 2025 Sohn Hearts & Minds Conference. Picture: Renee NowytargerQIao Ma presenting at the 2025 Sohn Hearts & Minds Conference. Picture: Renee NowytargerQIao Ma presenting at the 2025 Sohn Hearts & Minds Conference. Picture: Renee NowytargerQIao Ma presenting at the 2025 Sohn Hearts & Minds Conference. Picture: Renee Nowytarger
February 20, 2026

Qiao Ma on life in the ‘Darwinian’ world of funds management

The globetrotting stock picker, who reads dense corporate history books for fun, says AI will only replace those people who don’t know how to use it.

Read More
March 2, 2026

Howard Marks is the king of common sense. His AI verdict is chilling

The Oaktree Capital Management co-founder says artificial intelligence may be moving too quickly for society to adapt. But, there’s one group he believes is safe.

Read More
February 24, 2026

Outlook for global equities: what could surprise markets in 2026

Magellan Portfolio Managers' Alan Pullen and Casey McLean join Investment Director and Analyst, Elisa Di Marco to reflect on the volatile start to 2025 and the powerful AI-driven rally that followed, before looking ahead to what 2026 may bring.

Read More
March 13, 2026

3 knockout growth stocks from Munro's Qiao Ma

In this interview with Livewire Markets, Qiao explains how Munro manages risk when markets shift, where she sees the most exciting growth opportunities emerging, and three stocks she believes are particularly well positioned today.

Read More
March 20, 2026

5 big names reshaping the future - and 2 more offering growth

Vihari Ross (Antipodes) and Casey McLean (Magellan) break down 7 global names for investors looking beyond banks, miners and the ASX.

Read More
April 10, 2026

Finding opportunities in well-known names

Ryan Joyce of Magellan Investment Partners sits down with Equity Mates to discuss why some of the best opportunities can be found in the world’s biggest, most familiar companies. From TSMC and Booking Holdings to Dollar General and Apple.

Read More
March 31, 2026

AI disruption, real assets and opportunity in Australian equities

Magellan Investment Partners discuss how they navigate volatility by staying anchored to process, fundamentals and valuation. They unpack the resurgence of “real assets”, the sharp sell-off in software and classifieds and why AI disruption fears may be creating opportunities in quality businesses.

Read More
April 24, 2026

Nvidia has doubled in a year. This fundie says it’s undervalued

Kieran Moore is a portfolio manager focused on global equities at Munro Partners.

Read More
April 29, 2026

Inside Guzman y Gomez: CEO Steven Marks on growth, margins and the US gamble

GYG founder and boss is looking beyond short-term market pressure, with big plans for the chain's US expansion. Tune in as he discusses the challenge of cracking the US market, the role of drive-throughs and delivery, and the company's focus on food quality, speed and value.

Read More
May 1, 2026

13 stock picks for an energy shock and an AI boom

It’s a confusing time for investors, as they weigh the world’s biggest oil disruption against the largest tech surge. The Australian Financial Review asked six experts for their tips.

Read More
May 5, 2026

Tech Stocks are Hot Again: What to Buy (and What to Sell)

In this episode of In the Money, Kieran Moore Munro Partners unpacks what’s driving the rebound in growth stocks - and why he’s becoming more selective. He highlights the sharp rise in AI usage (or “token demand”) is rapidly accelerating, and explains how this is creating both significant opportunities and disruption risk.

Read More
May 18, 2026

Growth funds roar back as semiconductor stocks rocket

Munro Partners’ $1.7 billion Global Growth Fund was among the biggest beneficiaries of last month’s rally, returning 10 per cent in April thanks to its positions in Taiwan Semiconductor Manufacturing Company, Broadcom and Amazon.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.